Tech Company Financing Transactions
Diabeloop Funding Round
Diabeloop secured a $74.9 million Series C funding round on 6/2/2022. Investors included LBO France, Innovacom and Terumo.
Transaction Overview
Company Name
Announced On
6/2/2022
Transaction Type
Venture Equity
Amount
$74,900,000
Round
Series C
Investors
Proceeds Purpose
Diabeloop said it would use the funds to continue developing its AI-powered diabetes management technology and to both speed up and expand the commercial rollout of its existing tech around the world.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
155-157 cours Berriat
Grenoble, 38028
France
Grenoble, 38028
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Diabeloop partners with patients: Since its creation, Diabeloop has been involving people living with Type 1 diabetes and their families. They have contributed to the development alongside engineers and healthcare professionals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Erik Huneker
Browse more venture capital transactions:
Prev: 6/2/2022: Epic Sciences venture capital transaction
Next: 6/2/2022: Brevel venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs